1. Home
  2. BDSX vs CSBR Comparison

BDSX vs CSBR Comparison

Compare BDSX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$10.89

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.11

Market Cap

91.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
CSBR
Founded
2005
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.3M
91.0M
IPO Year
2020
1986

Fundamental Metrics

Financial Performance
Metric
BDSX
CSBR
Price
$10.89
$6.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$32.50
$12.00
AVG Volume (30 Days)
332.5K
6.3K
Earning Date
02-26-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
$80,173,000.00
$58,424,000.00
Revenue This Year
$22.01
$4.84
Revenue Next Year
$26.81
$11.51
P/E Ratio
N/A
$33.81
Revenue Growth
22.29
9.06
52 Week Low
$3.44
$5.59
52 Week High
$20.40
$11.82

Technical Indicators

Market Signals
Indicator
BDSX
CSBR
Relative Strength Index (RSI) 58.68 34.54
Support Level $9.81 $6.53
Resistance Level $10.79 $6.85
Average True Range (ATR) 1.29 0.38
MACD -0.07 -0.15
Stochastic Oscillator 53.85 3.87

Price Performance

Historical Comparison
BDSX
CSBR

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: